J.B. Chemicals & Pharmaceuticals Limited has officially relocated its registered office from Maharashtra to Gujarat, marking a significant corporate restructuring move. The Ministry of Corporate Affairs approved this transition on February 4, 2026, following the completion of all regulatory requirements.

Corporate Relocation Details

The pharmaceutical company has established its new registered office at a strategic location in Ahmedabad. The relocation process involved comprehensive regulatory compliance and formal approvals from multiple authorities.

Regulatory Compliance Process

The office relocation required substantial regulatory procedures under the Companies Act, 2013. The company passed a special resolution to alter provisions in its Memorandum of Association regarding the registered office location. This alteration was subsequently confirmed by Regional Director order bearing the date January 6, 2026.

The Certificate of Registration was issued under Section 13(5) of the Companies Act, 2013, by Sayali Gaikwad, Assistant Registrar of Companies at ROC Ahmedabad. The certification process transferred the company's jurisdiction from ROC Mumbai to ROC Ahmedabad.

Memorandum Amendment

Following the approved relocation, Clause II of the company's Memorandum of Association has been formally updated. The revised clause now states: "The registered office of the Company will be situated in the State of Gujarat."

This amendment reflects the company's commitment to establishing its legal domicile in Gujarat while continuing to maintain its corporate office operations at Energy IT Park, Unit A, 8th Floor, Appa Saheb Marathe Marg, Prabhadevi, Mumbai 400 025.

Corporate Structure

The company operates under Corporate Identity Number L24390GJ1976PLC173077 and maintains dual operational presence across states. While the registered office has moved to Gujarat, J.B. Chemicals continues its corporate operations from Mumbai, ensuring business continuity and operational efficiency.

Sandeep Anil Phadnis, serving as Designated Company Secretary and Director, communicated this development to BSE Ltd. in compliance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

J B Chemicals and Pharmaceuticals Limited has announced a key leadership change with the resignation of its Chief Financial Officer, Mr. Narayan Saraf, effective January 30, 2026. The announcement was made through a regulatory filing under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Resignation Details

Mr. Narayan Saraf, who serves as both Chief Financial Officer and Key Managerial Personnel of the company, tendered his resignation on January 28, 2026. The company has stated that the resignation is due to personal reasons and his desire to pursue other professional opportunities.

Regulatory Compliance

The disclosure was made in compliance with SEBI regulations, specifically referencing the SEBI Master Circular bearing reference number SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. The company has explicitly stated that there are no other material reasons for the resignation beyond those mentioned in the official communication.

Company Information

J.B. Chemicals & Pharmaceuticals Limited operates from its registered office at Neelam Centre, Worli, Mumbai, and maintains its corporate office at Energy IT Park, Prabhadevi, Mumbai. The company trades on BSE under scrip code 506943 with the stock symbol JBCHEPHARM. The pharmaceutical company's corporate identity number is L24390MH1976PLC019380, indicating its incorporation in Maharashtra in 1976.

The resignation represents a significant change in the company's key management personnel, with the CFO position becoming vacant effective January 30, 2026. The company has fulfilled its regulatory obligations by promptly disclosing this material information to the stock exchanges and stakeholders.